Douglas C. Bates
Fondateur chez Cyprotex US LLC
Profil
Douglas C.
Bates is the founder of Cyprotex US LLC.
He worked as a Non-Executive Director & Chief Marketing Officer at Cyprotex Ltd.
from 2010 to 2011.
Bates received his undergraduate degree from Dartmouth College, his graduate degree from the University of Pennsylvania, and his MBA from the Johnson Graduate School of Management.
Postes actifs de Douglas C. Bates
| Sociétés | Poste | Début |
|---|---|---|
Cyprotex US LLC
 Cyprotex US LLC Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Cyprotex US LLC is a company that provides contract research services specializing in preclinical ADME and Toxicology assessment. The company is based in Watertown, MA. Cyprotex US was acquired by Cyprotex Ltd., part of Evotec SE from December 15, 2016 on August 06, 2010 for $4.22 million. The company was founded by Douglas C. Bates, Katherine Tsaioun. | Fondateur | 03/12/2010 |
Anciens postes connus de Douglas C. Bates
| Sociétés | Poste | Fin |
|---|---|---|
| CYPROTEX PLC | Directeur/Membre du Conseil | 29/09/2011 |
Formation de Douglas C. Bates
| Dartmouth College | Undergraduate Degree |
| Johnson Graduate School of Management | Masters Business Admin |
| University of Pennsylvania | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Cyprotex Ltd.
 Cyprotex Ltd. Miscellaneous Commercial ServicesCommercial Services Cyprotex Ltd. provides pharmaceutical research and development services. It offers ADME and pharmacokinetic, Biosciences, in vitro skin and ocular testing, physicochemical profiling, in vitro toxicology, in silico prediction, and endocrine disruption. The company was founded by David Leahy in 1999 and is headquartered in Abingdon, the United Kingdom. | Commercial Services |
Cyprotex US LLC
Cyprotex US LLC Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Cyprotex US LLC is a company that provides contract research services specializing in preclinical ADME and Toxicology assessment. The company is based in Watertown, MA. Cyprotex US was acquired by Cyprotex Ltd., part of Evotec SE from December 15, 2016 on August 06, 2010 for $4.22 million. The company was founded by Douglas C. Bates, Katherine Tsaioun. | Commercial Services |
